Elevance Health Statistics Share Statistics Elevance Health has 237.46M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 237.46M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 237.04M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.27M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.27M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.53
Valuation Ratios The PE ratio is 18.66 and the forward
PE ratio is null.
Elevance Health's PEG ratio is
0.56.
PE Ratio 18.66 Forward PE n/a PS Ratio 0.82 Forward PS n/a PB Ratio 3.15 P/FCF Ratio 15.63 PEG Ratio 0.56
Financial Ratio History Enterprise Valuation Elevance Health has an Enterprise Value (EV) of 131.9B.
EV / Sales 0.95 EV / EBITDA 13.15 EV / EBIT 15.77 EV / FCF 18.13
Financial Position The company has a current ratio of 1.39,
with a Debt / Equity ratio of 0.64.
Current Ratio 1.39 Quick Ratio 1.39 Debt / Equity 0.64 Debt / EBITDA 2.3 Debt / FCF 3.16 Interest Coverage 10.94
Financial Efficiency Return on Equity is 16.9% and Return on Invested Capital is 8.63%.
Return on Equity 16.9% Return on Assets 6.25% Return on Invested Capital 8.63% Revenue Per Employee $1.41M Profits Per Employee $62.07K Employee Count 98,200 Asset Turnover 1.42 Inventory Turnover n/a
Taxes Income Tax 1.83B Effective Tax Rate 23.09%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.97, so Elevance Health's
price volatility has been higher than the market average.
Beta 0.97 52-Week Price Change n/a 50-Day Moving Average 493.45 200-Day Moving Average n/a Relative Strength Index (RSI) 51.21 Average Volume (20 Days) 1,177,335
Income Statement In the last 12 months, Elevance Health had revenue of 138.64B
and earned 6.09B
in profits. Earnings per share was 24.84.
Revenue 138.64B Gross Profit 138.64B Operating Income 8.73B Net Income 6.09B EBITDA 10.03B EBIT 8.72B Earnings Per Share (EPS) 24.84
Full Income Statement Balance Sheet The company has 4.88B in cash and 23.03B in
debt, giving a net cash position of -18.15B.
Cash & Cash Equivalents 4.88B Total Debt 23.03B Net Cash -18.15B Retained Earnings 27.09B Total Assets 100.82B Working Capital 29.28B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 8.36B
and capital expenditures -1.09B, giving a free cash flow of 7.28B.
Operating Cash Flow 8.36B Capital Expenditures -1.09B Free Cash Flow 7.28B FCF Per Share 29.65
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 6.3% and 4.4%.
Gross Margin 100% Operating Margin 6.3% Pretax Margin 5.72% Profit Margin 4.4% EBITDA Margin 7.24% EBIT Margin 6.3% FCF Margin 5.25%
Dividends & Yields ANTM pays an annual dividend of $5.95,
which amounts to a dividend yield of 0.99%.
Dividend Per Share $5.95 Dividend Yield 0.99% Dividend Growth (YoY) 13.27% Payout Ratio 23.42% Earnings Yield 5.36% FCF Yield 6.4%
Dividend Details Analyst Forecast Currently there are no analyst rating for ANTM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $263.3 Lynch Upside -45.44% Graham Number 286.56 Graham Upside -40.62%
Stock Splits The last stock split was on Jun 1, 2005. It was a
forward
split with a ratio of 2:1.
Last Split Date Jun 1, 2005 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.57 Piotroski F-Score 8
